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Abstract
Periodontitis is an infectious inflammatory disease that destroys the tooth-supporting (periodontal) tissues. Porphyromonas
gingivalis is an oral pathogen highly implicated in the pathogenesis of this disease. It can exert its effects to a number of
cells, including osteogenic bone marrow stromal cells which are important for homeostastic capacity of the tissues. By
employing gene microarray technology, this study aimed to describe the overall transcriptional events (.2-fold regulation)
elicited by P. gingivalis secreted products in bone marrow stromal cells, and to dissect further the categories of genes
involved in bone metabolism, inflammatory and immune responses. After 6 h of challenge with P. gingivalis, 271 genes
were up-regulated whereas 209 genes were down-regulated, whereas after 24 h, these numbers were 259 and 109,
respectively. The early (6 h) response was characterised by regulation of genes associated with inhibition of cell cycle,
induction of apoptosis and loss of structural integrity, whereas the late (24 h) response was characterised by induction of
chemokines, cytokines and their associated intracellular pathways (such as NF-kB), mediators of connective tissue and bone
destruction, and suppression of regulators of osteogenic differentiation. The most strongly up-regulated genes were
lipocalin 2 (LCN2) and serum amyloid A3 (SAA3), both encoding for proteins of the acute phase inflammatory response.
Collectively, these transcriptional changes elicited by P. gingivalis denote that the fundamental cellular functions are
hindered, and that the cells acquire a phenotype commensurate with propagated innate immune response and
inflammatory-mediated tissue destruction. In conclusion, the global transcriptional profile of bone marrow stromal cells in
response to P. gingivalis is marked by deregulated homeostatic functions, with implications in the pathogenesis of
periodontitis.
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Introduction
Periodontitis is as a condition characterised by a bacterially-
induced inflammatory destruction of the tooth-supporting (peri-
odontal) tissues, including the alveolar bone and the intercon-
necting periodontal ligament. Porphyromonas gingivalis is a Gram-
negative anaerobe highly associated with chronic periodontitis. It
is frequently and at high levels detected in diseased sites,
particularly with active disease progression, but rarely or at low
levels in healthy sites [1,2]. P. gingivalis is considered notorious for
its capacity to manipulate the host innate immune and
inflammatory responses, as a strategy to survive and prevail into
the periodontal tissue habitat [3–5]. A number of virulence
factors, such as its cysteine proteinases (gingipains), lipopolysac-
charide (LPS) and fimbriae [6], collectively contribute to these
properties of P. gingivalis.
Bone marrow stromal cells have osteogenic protential and can
give rise to bone forming osteoblasts under the appropriate
stimulation [7]. Among other cells types, bone marrow stromal
cells are also a target for P. gingivalis. A number of studies have
focused on the capacity of P. gingivalis to trigger mechanisms of
bone resorption in these cells [8–10], which is a key histopath-
ological trait of periodontitis. There are also studies addressing the
global effect of P. gingivalis on stromal cells, using gene microarray
technology. These have demonstrated that approximately 360
genes were up-regulated (greater than 2-fold) in response to P.
gingivalis, including genes encoding for chemokines, pro-inflam-
matory cytokines and matrix metalloproteinases (MMPs) [11].
Moreover, they have identified signalling pathways that may be
involved in the pro-inflammatory responses to P. gingivals,
predominantly the activation of transcription factors nuclear
factor-kappaB (NF-kB) and activator protein (AP)-1 [12].
Nevertheless, the full range of transcriptional changes inflicted
in bone marrow stromal cells by P. gingivalis with potential
implications in the pathogenesis of periodontal disease is yet to be
determined. Therefore, by employing gene microarray technolo-
gy, the aim of the present study was to describe the overall
transcriptional effects of P. gingivalis on osteogenic bone marrow
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stromal cells over time, dissecting the categories of genes involved
in bone metabolism, inflammatory and immune responses, which
are all associated with the pathogenesis of periodontal disease.
Materials and Methods
Preparation and Growth of Porphyromonas gingivalis
Porphyromonas gingivalis W50 strain (provided by Centre of
Immunology and Infectious Disease, Blizard Institute of Cellular
and Molecular Science, Barts and the London School of Medicine
and Dentistry) was grown on blood agar plates supplemented with
5% horse blood in an anaerobic environment containing 80%
nitrogen, 10% hydrogen and 10% carbon dioxide at 37uC for
3 days, before then being sub-cultured into 10 ml of media
consisting of brain heart infusion (BHI) broth supplemented with
5 mg/ml of hemin. The following day, the 10 ml culture was
inoculated into 90 ml of fresh media. This was considered day 0 of
the culture. At day 6, the bacterial cultures were centrifuged at
8500 rpm for 45 min at 4uC, and the resulting bacterial
supernatant was removed, aliquoted and stored at 280uC for
further use to challenge the cells. In further mentions within the
text, this preparation is referred to simply as ‘‘P. gingivalis’’, for
reasons of clarity.
Bone Marrow Stromal Cell Culture and Challenge with
Porphyromonas gingivalis
An established murine bone marrow stromal cell line, W20-17
[7], was used in this experimental system, as previously described
[9,10]. Cell culture was carried out in alpha minimum essential
medium (a-MEM, Gibco-BRL) supplemented with 10% v/v foetal
calf serum, 50 U/ml penicillin, 50 mg/ml streptomycin (Gibco-
BRL) and 50 mg/ml of ascorbic acid (Sigma). The cell cultures
were incubated at 37uC in an atmosphere of 5% CO2. For sub-
culturing, the cells were detached from the bottom of the culture
flask with 0.1% Trypsin/EDTA (Gibco) and centrifuged at
1000 rpm for 5 min at room temperature. For the experiments,
the cells were seeded at a density of 26104 cells/cm2 and left to
attach for at least 18 h before being challenged with the P. gingivalis
culture supernatants. When thawed, the aliquoted bacterial
supernatants were filter-sterilized (0.2 mm filter) and added into
the cell culture at 5 mg/ml total bacterial protein concentration.
The cultures were further incubated at 37uC in the presence of 5%
CO2 for 6 h and 24 h. The selection of this concentration of P.
gingivalis and challenge period was based on earlier studies
demonstrating effects on gene expression by the cells, in the
absence of cytotoxicity [9,10]. Untreated cell cultures served as
controls. For each group, four biological replicates were used.
Gene Microarray Protocol
To investigate the gene expression profile of W20-17 bone
marrow stromal cells challenged with P. gingivalis, the Illumina
Whole-Genome Expression Assay was used (MouseRef-8 v2.0
Expression BeadChips). The Illumina technology consists of
oligonucleotides immobilised to beads in microwells contained in
the array that bind to complimentary sequences contained in the
target template. After the cells were challenged with 5 mg/ml
protein concentration of P. gingivalis supernatant for 6 h and 24 h,
the cell culture supernatant was removed and total RNA was then
extracted and collected from the cells by the RNeasy Mini Kit
(QIAGEN). This was performed for all four biological replicates in
each group. From each sample, 250 ng of high quality total RNA
were biotin-labelled with a single round amplification using the
Illumina total preparation kit (LifeTech). Spike RNA controls were
also included within samples prior to amplification, in order to
confirm a successful reaction. The biotin-labelled cRNA was then
quantified using a Nanodrop spectrometer. To confirm the quality
of the RNA, the fragment size distribution of ribosomal RNA was
assessed by electrophoresis on a RNA nano-chip on the
Bioanalyser (Agilent). A total of 750 ng of cRNA was then
hybridised to the MouseRef-8 v2 array (Illumina) according to the
manufacturer’s instructions and data was visualised on the Bead
Array Reader (Illumina). This assay was performed at the core
facilities of the Genome Centre of Barts and The London School
of Medicine and Dentistry.
Gene Microarray Data Analysis
Intensity data from the Bead Array Reader was imported into
the BeadStudio software (Illumina) to be analysed. Quality control
checks were performed based on spiked-in controls. Data fulfilling
the quality criteria were then quantile-normalised before grouping
replicates and performing group differential analysis using the
Beadstudio software. Further to this, a Bonferonni statistical test
was performed to adjust for a large number of p values, which
were then converted to differential (diff) scores. This takes into
account both the p value and the difference between the average
signal of the reference and comparison group (in this case the
control group versus the P. gingivalis-challenged group). A p value
of 0.001 is equivalent to a diff score of633. For further stringency,
an arbitrary cut-off diff score of 665 was chosen. Over 24,000
transcripts were assayed and to narrow the frame of reference a
cut-off threshold of 2-fold regulation (up- or down-) was chosen.
Where applicable, a small number of genes of interest lower than
2-fold were also included. The list of genes together with fold
changes was uploaded into the Ingenuity software (Ingenuity
SystemsH, http://www.ingenuity.com), which was then used to
sort the list of genes into broad cellular categories.
Validation using Quantitative TaqManH Real-time PCR
(qPCR)
To validate the microarray results, the mRNA expression levels
of a selected number of genes were alternatively quantified by
qPCR, on cDNA prepared from the samples. For the amplifica-
tion reactions, Applied Biosystems (ABI) TaqManH Gene Expres-
sion Assays and the ROX mastermix were used. The qPCR
reactions and analyses were performed in an ABI Prism 7900HT
Sequence Detection System. The amplification conditions were
10 min at 95uC, followed by 40 cycles at 95uC for 15 sec and
60uC for 1 min. The TaqManH Gene Expression Assays IDs for
the studied target genes were as follows: TNFSF11 (RANKL):
Mm00441908_m1, TNFRSF11B (OPG): Mm00435452_m1,
COX-2: Mm00478377_g1, SAA3: Mm00441203_m1, and
LCN2: Mm01324470_m1. To be able to normalise the obtained
target gene Ct values, a housekeeping gene screen was performed
in cDNA from W20-17 cells, using a series of 12 murine
housekeeping gene candidates. The screen performed indicated
that the eukaryotic translation initiation factor 4A, isoform 2
(EIF4A2: Mm008343457_g1) and cytochrome 1 (CYC1:
Mm00470540_g1) gene expressions were the most stable and
consistent among all, and were used to normalise the data. For
each sample, the relative target gene expression was determined as
the DCt value, which is the difference between the target gene Ct
and the average Ct of the selected two housekeeping genes.
Statistical Analysis
The data on qPCR validation experimentations were analysed
by Student’s t test in order to determine statistical significance of
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differences between the corresponding P. gingivalis challenged and
control groups.
Results and Discussion
The global transcriptional effects of P. gingivalis on bone marrow
stromal cells were evaluated by an Illumina bead gene microarray
(MouseRef-8 v2.0 Expression BeadChips). W20-17 bone marrow
cells were challenged with 5 mg/ml of P. gingivalis W50 culture
supernatant, over a 6 h or 24 h time period. It is anticipated that
the selection of these two time-points correspond respectively to
periods of early and late responses to P. gingivalis. Moreover, it is
know from earlier studies in the present experimental system that
P. gingivalis challenge does not elicit significant cytotoxicity during
these periods [9,10].
Relative changes of gene expression induced by P. gingivalis in
bone marrow stromal cells were determined by normalising
against the corresponding control group. More than 24,000
transcripts were assayed. To narrow-down the frame of reference,
a cut-off threshold of 2-fold was selected. A small number of genes
exhibiting lower than 2-fold regulation were also included in the
analyses, since these were of focus in earlier gene expression
studies employing the present experimental model [9,10], in order
to validate these earlier results.
Global Gene Regulation
The collective data indicates that 480 genes were regulated
more than 2-fold after 6 h (Table S1), whereas 364 genes were
regulated more than 2-fold after 24 h (Table S2). In particular,
after 6 h of challenge, P. gingivalis caused up-regulation of 271
genes and down-regulation of 209 genes, whereas after 24 h of
challenge, 259 genes were up-regulated and 109 genes were down-
regulated.
Functional Classification of Regulated Genes
The genes that were regulated more than 2-fold were further
categorised according to their known cellular function using the
Ingenuity Pathway Analysis (Ingenuity SystemsH, http://www.
ingenuity.com). The top five cellular functions and the
corresponding percentage of their up- and down-regulated
genes at both time-points are displayed in Table 1. Interestingly,
a bi-phasic response was demonstrated by this data. An early
6 h-response to P. gingivalis was characterised by regulation of
genes associated with cell movement, growth, proliferation and
intracellular signalling. However, the late 24 h time-point was
characterised by the regulation of genes associated with the
immune and inflammatory response, including the categories of
immunological disease, antigen presentation, cell-mediated and
humoral immunity. A marked overlap between the two time-
points was the regulation of genes with associated functions in
cancer. This should not imply that P. gingivalis is involved in
carcinogenesis, as this category is broad enough to include genes
with roles in cell growth, proliferation and apoptosis, functions
which are all affected by P. gingivalis challenge. Further focus is
placed on the gene categories with ascribed roles in inflamma-
tory processes and skeletal/muscle disorders (i.e. bone metab-
olism), according to Table 2. The reason for this filtering is that
periodontal disease has combined inflammatory and bone
destruction traits. Therefore, looking in more detail into these
categories is of relevance to the disease. Within these categories,
results are presented and discussed according to clustering of the
regulated genes based on cellular and molecular function.
Apoptosis, Regulation of Cell Cycle and Structural
Integrity
In response to P. gingivalis challenge, the transcription of three
genes with involvement in apoptotic processes was regulated.
These were namely caspase 4 (CASP4), tumor necrosis factor
receptor superfamily member 6 (FAS) and engulfment adaptor
PTB domain containing 1 (GULP1). These were all up-regulated
at both 6 h and 24 h (Table 2, apoptosis related genes), suggesting
mechanisms by which P. gingivalis challenge may induce the
apoptosis. P. gingivalis has been previously shown to induce
apoptotic cell death in fibroblasts, endothelial cells and epithelial
cells [13–15], and that its gingipains in particular may have a role
in this effect [15].
The expression of a number of genes that encode for cell cycle-
regulatory proteins was also affected by P. gingivalis. After 6 h of
challenge, the negative regulators of cell cycle p16 and p21 were
up-regulated by 2.0- and 5.3-fold, respectively, while p18, another
inhibitor of the cell cycle, was down-regulated by 2.0-fold. Cyclin
D1, the only positive regulator of the cell cycle to be affected, was
down-regulated by 3.1-fold over a 24 h period of challenge
(Table 2, Cell cycle genes). Cyclin D1 is crucial for entry into the
G1 phase, whereas p16 and p21 are responsible for arresting the
cell cycle in G1 phase. Collectively, the effects on P. gingivalis on
these genes would imply a possible G1 phase arrest of the cells. To
this extent, there is evidence that P. gingivalis decreases cyclin D1
expression, causing G1 phase arrest of the cell cycle [16,17]. This is
shown to be concomitant to an up-regulation of p16 and p21 levels
[17], and mainly attributed to the gingipains of P. gingivalis [16].
The expression of claudin 15 (CLDN15), a structural protein of
tight junctions, was down-regulated by 2.9 and 3.2 at 6 h and
24 h, respectively. Other structural genes that were down-
regulated at 24 h include caveolin 1 (CAV1), an integral
membrane scaffolding protein, and vimentin (VIM), an interme-
diate filament (Table 2, Structural genes). Interestingly, the
extracellular matrix GLA protein (MGP) normally associated with
bone and cartilage was down-regulated by 22.9 fold at 24 h
(Table 2, Extracellular matrix proteins).
Collectively, the results in the present experimental system
indicate an overall positive effect of P. gingivalis on apoptosis,
accompanied by a negative effect on cell cycle progression and
cell-structural integrity, which are initiated at 6 h and culminated
at 24 h. All of these events corroborate an involvement of P.
gingivalis in the pathogenesis of periodontal disease, by early
disruption of tissue homeostasis.
Chemokine, Cytokines and other Inflammatory Mediators
The regulation of inflammatory chemokines and cytokines
groups by P. gingivalis challenge was further investigated.
Chemokines are essentially cytokines that are involved in
recruiting leukocytes to inflammatory sites. Their recruitment is
an act of protection against bacterial invasion, but over-
stimulation can conversely lead to tissue destruction. In the
present experimental system, after 24 h of challenge, the most
strongly up-regulated chemokine was LPS-induced CXC chemo-
kine (also named CXCL5) by a marked 112.0-fold, followed by
chemokine C-C motif ligand 5 (CCL5) by 86.8-fold, and
chemokine C-X-C motif ligand 9 (CXCL9) by 35.0-fold
(Table 2, Chemokine and cytokines). Other up-regulated chemo-
kines include CCL17, CCL2, CCL3, CCL7, CCL9, CXCL1,
CXCL10 and CXCL2. These findings are in line with earlier
studies on bone marrow stromal cells, whereby P. gingivalis elicited
a similar chemokine profile by the cells, suggested to be attributed
to the effect of gingipains or LPS [11]. Porphyromonas gingivalis has
also been shown to induce the expression of CCL2 in endothelial
P. gingivalis and Bone Marrow Stromal Cells
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cells [18] and CCL2 and CCL5 in bone-marrow derived cells
[19]. Evidence from clinical biopsies demonstrates that CCL2 and
CCL5 gene expressions are up-regulated in aggressive and chronic
periodontitis [20]. Therefore, the progressive induction of
chemokines by P. gingivalis could facilitate the recruitment of
inflammatory cells on site, and corroborate the establishment of
chronic inflammation.
Among the interleukin (IL) family of cytokines, the pro-
inflammatory IL-1a and IL-6 were increased at 24 h by 6.5-fold
and 23.2-fold, respectively. However, the expression of IL-15, a
cytokine that regulates T-cell and natural killer cell activation and
proliferation, was down-regulated by 2.3-fold at this time-point. In
support of these findings, P. gingivalis has been previously shown to
stimulate of IL-6 mRNA [8,21] and protein expression [22].
Earlier work has also confirmed the induction of IL-1a production
in human monocytes in response to P. gingivalis, albeit to a weaker
extent that other putative periodontal pathogens [23]. Both IL-1a
and IL-6 are considered as key cytokines in the stimulation of
mechanisms of bone resorption [24].
Further data on the regulation of cytokines and mediators of
bone resorption is presented. Macrophage-colony stimulating
factor (M-CSF) 1 is a cytokine required for survival, proliferation
and differentiation of hematopoeitic cells into osteoclasts. M-CSF
1 expression was increased by 2.7-fold in response P. gingivalis, after
6 h. Additionally, RANKL expression, the key stimulator of
osteoclast differentiation, was up-regulated at 24 h by 1.9 fold
(Table 2, Cytokines), whereas the expression of OPG, the natural
inhibitor of RANKL, and subsequently of bone resorption, was
down-regulated by 4.0-fold as early as 6 h (Table 2, Receptor
genes). These changes in RANKL and OPG gene expression are
well in line with earlier results in this experimental system, which
also demonstrated concomitant changes on the protein level
[9,10]. P. gingivalis has also been shown to up-regulate RANKL
and down-regulate OPG gene expression in periodontal ligament
cells and gingival fibroblasts [25]. Activated B-cells and T- cells
can also express RANKL [26] and P. gingivalis stimulates further its
expression in T-cells [27]. Prostaglandin (PG)E2 is a major
inflammatory mediator of bone resorption, which can also induce
the expression of RANKL expression [9,10,27]. It is well
established that PGE2 is involved in the pathogenesis of
periodontitis [28] and the stimulation of bone resorption [29].
Key enzymes involved in PGE2 synthesis are COX-2 and
prostaglandin E synthase (PTGES). The gene expression of
COX-2 was increased in response to P. gingivalis by 3.2-fold and
2.3-fold at 6 h and 24 h respectively, whilst PTGES expression
was increased by 3.2-fold at 6 h. These findings are in line with
earlier studies demonstrating the up-regulation of PGE2 in various
cell types by P. gingivalis [8,27,30]. Collectively, this microarray
data confirms that P. gingivalis enhances the gene expression of a
number of inflammatory mediators, providing favourable condi-
tions for the stimulation of osteoclastogenesis and bone resorption.
Haptoglobin (Hp), a protein that binds haemoglobin in plasma,
is associated with acute phase response. It prevents heme-mediated
oxidative damage to internal organs upon haemolysis during
pathologic conditions, such as bacterial infections [31]. In the
present experimental system, P. gingivalis caused up-regulation of
Hp expression by 2.6-fold and 7.5-fold, at 6 h and 24 h,
respectively. The expression of hemopexin (Hpx), a protein that
binds heme, was also up-regulated by 7-fold at 24 h. Systemic Hp
levels are shown to be higher in individuals with periodontitis,
compared to periodontally healthy ones [32]. Therefore, the up-
regulation of Hp expression by P. gingivalis may theoretically
contribute to the presence of systemic inflammatory response.
Another important consideration is that P. gingivalis utilizes hemin
to receive iron for its growth, a process inhibited by host iron-
sequestering (binding) proteins, including Hp and Hpx, which
form complexes with haemoglobin and heme, respectively, within
blood plasma, thereby denying iron to bacteria. As P. gingivalis can
grow in the presence of these complexes, it has been suggested that
it may possess a mechanism through which it is able to utilize iron
from them [33]. In fact, the capacity of P. gingivalis Lys-specific
gingipain to degrade Hp and Hpx with subsequent release of
hemin from these complexes could constitute a mechanism that
facilitates its growth [34]. Therefore, the up-regulation of Hp and
Hpx by P. gingivalis may enhance binding of iron from hemin,
which is required within its nutrient milieu.
Table 1. Top five regulated gene categories according to cellular function.
Genes regulated after 6 h
Cellular function Up-regulated Down-regulated
Cancer 33% 22%
Cellular Movement 16% 10%
Cellular growth and proliferation 24% 20%
Cell-to-cell signalling 14% 9%
Haematological system (development and function) 17% 6%
Genes regulated after 24 h
Cellular function Up-regulated Down-regulated
Cancer 36% 33%
Immunological disease 25% 9%
Antigen presentation 29% 7%
Cell-mediated immune response 28% 10%
Humoral immune response 26% 7%
The percentage of genes regulated within each category is provided.
doi:10.1371/journal.pone.0043899.t001
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Table 2. Genes regulated by P. gingivalis and associated with the categories of Skeletal/Muscle disorders and inflammatory
response.
Gene category
Fold Change
(6 h) Fold Change (24 h)
Skeletal & Muscle
Development &
Function
Skeletal & Muscle
Disorders Inflammatory Response
Apoptosis genes
Caspase 4 (CASP4) 2.8 4.3 X
Tumor necrosis factor receptor
superfamily member 6 (FAS)
7.8 11.5 X X
Cell cycle genes
Cyclin D1 23.1 X
p16 2.0 X X
p21 5.3 X X X
Chemokines and cytokines
CCL17 8.0 3.1 X X
CCL2 17.6 20.7 X X X
CCL3 3.3 40.0 X X X
CCL5 9.0 86.8 X X
CCL7 2.8 3.7 X X X
CCL9 7.2 8.3 X X
CX3CL1 10.6 4.7 X
CXCL1 23.1 29.2 X X
CXCL10 7.1 5.9 X X
CXCL15 6.8 X X
CXCL2 2.6 3.0 X X
CXCL4 2.3 X
CXCL5 112.0 X
CXCL7 16.0 X
CXCL9 10.5 35.0 X X
Interleukin 1, alpha (IL-1a) 6.5 X X X
Interleukin 15 (IL-15) 22.3 X X
Interleukin 6 (IL-6) 23.2 X X X
Macrophage colony stimulating
factor 1 (M-CSF1)
2.7 X X X
Macrophage colony stimulating
factor 2 (M-CSF2)
2.4 X X X
Receptor activator of nuclear
factor-kB ligand (RANKL)
1.9 X X X
Tumor necrosis factor
(ligand) superfamily,
member 13b (TNFSF13B)
3.4 X X
Extracellular matrix genes
Matrix GLA protein (MGP) 22.9 X
Growth factor genes
Bone morphogenic protein 4 (BMP4) 22.2 X X
Hepacyte growth factor (HGF) 2.3 X X
Vascular endothelial growth
factor (VEGF)
2.1 2.8 X X X
Guanosine triphosphate enzymes (GTPase) genes
GTP cyclohydrolase 1 (GCH1) 9.0 X
Guanylate binding protein 2 (GBP2) 4.4 16.3 X
Hormones
Inflammation genes
Cyclooxygenase-2 (COX-2) 3.2 2.3 X X X
Haptoglobin (Hp) 2.6 7.5 X
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Table 2. Cont.
Gene category
Fold Change
(6 h) Fold Change (24 h)
Skeletal & Muscle
Development &
Function
Skeletal & Muscle
Disorders Inflammatory Response
Hemopexin (Hpx) 7.0 X
Lipocalin 2 (Lcn2) 33.6 354.8 X
Lipolysaccharide binding protein (LBP) 2.4 X
Myeloid differentiation protein-2 (MD-2) 22.3 X
Prostaglandin E synthase (PTGES) 3.2 X
Serum amyloid A3 (SAA3) 144.8 143.9 X X
Superoxide dismutase 2 (SOD2) 2.3 3.2 X X X
Immune related genes
Cathelicidin antimicrobial
peptide (CAMP)
9.4 X
Complement component 1s (C1s) 2.6 X X
Complement component 3 (C3) 14.3 X X
Complement component 4B (C4B) 2.3 X X
Complement factor B (CFB) 19.9 X X
DHX58 2.7 X
Interferon gamma inducible protein 47
(IFI47)
3.1 2.9 X
Interferon induced transmembrane
protein 3 (IFITM3)
3.2 X
Interferon, alpha-inducible protein 27
(IFI27)
2.6 X
Macrophage antigen CD68 2.0 X
Major histocompatibility 2, M region
locus 3 (H2–M3)
2.0 2.0
Major histocompatibility complex,
class I, C (HLA-C)
2.6 X X
Major histocompatibility complex,
class I, E (HLA-E)
2.8 X
Major histocompatibility complex,
class II, DM alpha (HLA-DMA)
2.0 X X
Major histocompatibility complex,
class II, DQ beta 2 (HLA-DQb2)
3.4 X X
Pentraxin 3, long (PTX3) 11.9 32.0 X
Retinoic acid-inducible gene 1
protein (RIG-1)
2.2 X
S100 calcium binding protein A8
(S100A8)
3.4 X X
Spondin 2 (SPON2)* 2.2 2.8
Ubiquitin D (UBD)* 2.2 3.2
Proteases and related genes
A disintegrin and metalloproteinase
domain 12 (ADAM12)
22.4 X
A disintegrin-like and metalloproteinase
with thrombospondin (ADAMTS7)
2.1 X
Cathepsin L (CTSL) 2.2 X X
Matrix metalloproteinase 12 (MMP12) 2.9 X
Matrix metalloproteinase 13 (MMP13) 9.3 8.4 X X
Matrix metalloproteinase 13 (MMP17) 3.4 X X
Matrix metalloproteinase 14 (MMP14) -2.2 X X
Matrix metalloproteinase 3 (MMP3) 35.8 X X
Matrix metalloproteinase 9 (MMP9) 3.0 X X
Proteasome subunit, beta type,
8 (PSMB8)
2.1 X
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Table 2. Cont.
Gene category
Fold Change
(6 h) Fold Change (24 h)
Skeletal & Muscle
Development &
Function
Skeletal & Muscle
Disorders Inflammatory Response
Secretory leukocyte peptidase
inhibitor (SLPI)
4.9 19.5 X
Tissue inhibitor of
metalloproteinase 1 (TIMP1)
2.1 X
Receptor genes
CD44 2.2 X X X
Cluster of differentiation 14 (CD14) 2.1 X
Interferon Receptor 2 (IFNAR2) 2.7 X X
Interleukin 1 receptor antagonist
(IL1RN)
23.9 X X X
Interleukin 10 receptor,
beta (IL10RB)
2.0 X
Interleukin 13 receptor,
alpha 1 (IL-13RA1)
4.1 X
Interleukin 13 receptor,
alpha 2 (IL-13RA2)
11.0 X
Osteoprotegerin (OPG) 24.0 X X
Toll like receptor 2 (TLR-2) 3.7 12.6 X X X
Tumor necrosis factor receptor
superfamily, member 9 (TNFRSF9)
3.9 X X
Structural genes
Caveolin 1 (CAV1) 22.1 X X
Vimentin (VIM) 22.1 X
Signal transduction genes
B-cell lymphoma 3-encoded protein
(BCL3)
2.7 X
Growth arrest and DNA-damage-
inducible, beta (GADD45B)
2.6 X
Immediate early response 3 (IER3) 4.9 5.5 X
Inhibitor of kappa light polypeptide
gene enhancer in B-cells, kinase
epsilon (IkBKE)
1.7 X
Inhibitor of kappa light polypeptide
gene enhancer in B-cells,
kinase gamma (IkBKG)
1.7 X
Interleukin-1 receptor-associated
kinase 3 (IRAK3)
2.3 X X
Janus kinase 2 (JAK2) 6.9 X
Myeloid differentiation primary
response gene (88) (MYD88)
1.7 X X X
Nuclear factor of kappa light
polypeptide gene enhancer in
B-cells inhibitor (NF-kBIA)
4.6 5.7 X X X
Nuclear factor of kappa light
polypeptide gene enhancer
in B-cells inhibitor (NF-kBIZ)
11.2 9.6 X
Receptor-interacting serine-
threonine kinase 2 (RIPK2)
2.4 2.9 X
Suppressor of cytokine signalling 3
(SOCS3)
2.3 4.5 X X X
TNFAIP3 interacting protein 1 (TNIP1) 2.7 5.9 X
Tumor necrosis factor, alpha-induced
protein 3 (TNFAIP3)
2.4 4.8 X X X
WNT1 inducible signalling pathway
protein 2 (WISP2)
22.6 X
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Interestingly, within this category of inflammation-related genes
were also two among the most regulated ones, namely lipocalin 2
(LCN2) and serum amyloid A3 (SAA3). LCN2 expression
exhibited a dramatic increase in response to P. gingivalis, which
was 33.6-fold and 354.8-fold at 6 h and 24 h, respectively. SAA3
expression was also strongly up-regulated in response to P. gingivalis
by 144.8-fold and 143.9-fold at 6 h and 24 h, respectively (Table 2,
Inflammation genes). LCN genes encode for small glycoproteins,
which arise as part of the acute phase response, with involvement
in the innate immune response to bacterial infection. LCN2 exerts
antimicrobial effects by sequestering bacterial siderophores and
inhibiting the growth of iron-dependent bacteria [35]. Although,
P. gingivalis does not use sidephores to sequester iron [36], but
rather haemophores [37,38] the dramatic up-regulation of LCN2
expression may still constitute an iron-sequesteing based antimi-
crobial response, aiming to limit its growth. The SAA family of
proteins are also involved in the acute phase response, consisting of
four isoforms. SAA3 is an active isoform in mice [39], with 70%
amino-acid sequence homology and overlapping function to
human SAA1 [40]. The strong up-regulation of SAA3 transcrip-
tion in response to P. gingivalis in the present experimental system is
in line with earlier work on murine ST2 stromal cells challenged
with another P. gingivalis strain, demonstrating an 11.5-fold after
6 h of challenge [11]. Sustained production of SAA proteins can
lead to amyloidosis, through fibril deposition, and consequently to
chronic inflammatory conditions [41]. A link may exist between
amyloidosis and periodontal disease, where one condition may
predispose to, or aggravate, the other [42,43]. Interestingly,
periodontitis patients exhibit higher SAA blood serum levels than
healthy individuals [44]. Therefore, SAA protein levels could serve
as a potential biomarker for periodontal disease progression, or
could constitute a potential molecular link between periodontal
diseases and systemic inflammatory conditions. In this line, the
involvement of SAA3 requires further clinical investigation.
Immune System
Porphyromonas gingivalis also stimulated the expression of a
number of immune related genes by the cells (Table 2, Immune
related genes). Cathelicidin antimicrobial peptide (CAMP) expres-
sion, a protein that exhibits antibacterial activity, was up-regulated
by 9.4-fold at 24 h. CAMP has a role in the endosomal
degradation of the bacterial cell membrane during phagocytosis,
and can also bind to LPS, thus inhibiting its biological activity
[45]. Mesenchymal stromal cells can also secrete CAMP in
response to Gram-negative bacteria, which can in turn inhibit
their growth [46]. Moreover, CAMP can inhibit host pro-
inflammatory responses elicited by P. gingivalis, or its LPS and
fimbriae. Although the present data on CAMP could indicate a
potential antimicrobial response of P. gingivalis, it has also been
shown that this species is resistant to the anti-microbial actions of
CAMP [47,48].
Genes encoding for complement proteins C1s, C3, C4B and
complement factor B (CFB) were also up-regulated at 24 h. It is
well known that P. gingivalis is also able to degrade complement
factors [49,50]. In particular, its gingipains can either degrade or,
at low concentrations, activate complement factors [51], and Arg-
X and Lys-X gingipain mutants have increased susceptibility to
complement killing, compared to wild-type P. gingivalis [52]. The
induction of the expression of complement factors by P. gingivalis
suggests that cells are mounting an immune response aimed at
Table 2. Cont.
Gene category
Fold Change
(6 h) Fold Change (24 h)
Skeletal & Muscle
Development &
Function
Skeletal & Muscle
Disorders Inflammatory Response
V-rel reticuloendotheliosis viral
oncogene homolog B (REL-B)
4.0 X
Transcription factor and inhibitor genes
CCAAT/enhancer-binding protein
beta (CEBPb)
3.4 4.2 X X X
FBJ murine osteosarcoma viral
oncogene homolog (c-Fos)
1.7 1.4 X X X
Hairy-related transcription
factor 1 (HEY1)
2.1 X
Jun B proto-oncogene (JUNB) 2.6 5.4 X X
Nuclear factor of kappa light
polypeptide gene enhancer
in B-cells 1 (NF-kB1)
2.6 X X
Nuclear factor of kappa light
polypeptide gene enhancer
in B-cells 2 (NF-kB2)
2.2 X
Sex determining region Y box 9
(SOX-9)
23.1 X X X
Signal transducer and activator of
transcription 3 (STAT3)
2.6 2.6 X X X
V-rel reticuloendotheliosis viral
oncogene homolog A (avian) (REL-A)
1.5 X
The genes regulated more than 2-fold by P. gingivalis were categorized according to ascribed roles in a) skeletal and muscle development and function, b) skeletal and
muscle disorders, and c) inflammatory responses (horizontal categories). Within each of these thee categories, genes were sub-categorized according to ascribed
cellular function (vertical categories). The fold-changes in expression (compared to control) at 6 h and 24 h are provided. The minus values (also in bold letters) indicate
down-regulation. When a –fold change value is missing in one of the two time-points, the regulation of gene expression at that time-point was less that 2-fold.
doi:10.1371/journal.pone.0043899.t002
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clearing bacterial infection. Nevertheless, there is recent evidence
that P. gingivalis manipulates innate immunity by controlling the
cross-talk between complement factors and the host [53–57]
Therefore, the induction of complement-associated genes observed
in this experimental model may well be an attempt of P. gingivalis to
confuse the innate immune host responses.
Other strongly up-regulated genes linked with innate immunity
were Pentraxin 3 (PTX3), Spondin 2 (SPON2) and Ubiquitin D
(UBD). A notable up-regulation was observed in the case of PTX3,
which was 11.9-fold and 32.0-fold, at 6 h and 24 h, respectively.
PTX3 protein is induced in response to stimulation with LPS or
inflammatory cytokines, and is involved in a variety of innate
immunity and inflammatory processes [58]. With regards to
periodontitis, PTX3 levels are associated with the severity of the
disease [59], and diseased sites foster higher PTX3 levels
compared to healthy ones [60]. In line with the present
observations, P. gingivalis LPS and fimbriae have been shown to
induce PTX3 expression in macrophages [61].
Growth Factors
The transcription of some growth factors was also affected by P.
gingivalis challenge. In particular, a down-regulation was evident in
the expressions of bone morphogenic protein (BMP)4 and
transforming growth factor b-3 (TGFb3). BMP4 is a key gene in
the process of stimulating osteoblastic differentiation [62], and this
was down-regulated by 2.2-fold at 6 h. TGFb3 has crucial roles in
osteogenic and chondrogenic differentiation by bone marrow
stromal cells and its expression was decreased by 2.1-fold and 2.5-
fold, at 6 h and 24 h, respectively, in the present experimental
system. Collectively, these effects of P. gingivalis suggest a potential
inhibition of the osteogenic and chondrogenic differentiation
capacities of the studied cells.
On the contrary, the gene expressions of vascular endothelial
growth factor (VEGF) and hepatocyte growth factor (HGF) were
up-regulated after 24 h of challenge with P. gingivalis by 2.8-fold,
and 2.3-fold, respectively (Table 2, Growth factors genes). VEGF
is a potent inducer of angiogenesis and increased vascular
permeability. Increased vascularisation, swelling and oedema are
characteristic of periodontal inflammation. To this extent, several
studies implicate VEGF in the progression of periodontitis, since
increased VEGF levels were observed in diseased gingival tissue
[63] or GCF from diseased sites [64], compared to healthy ones.
In line with the present findings, it has been shown that P. gingivalis
vesicles and outer membrane proteins increased VEGF expression
in human gingival fibroblasts [65]. Collectively, these findings
suggest a mechanism by which P. gingivalis can promote
angiogenesis and vascular permeability during the progress of
periodontitis. Moreover, the increased vascularisation can subse-
quently lead to increased hemin concentrations, which are much
requited for the growth of P. gingivalis.
Proteases
The regulation of genes encoding for some proteases and other
functionally similar proteins was also affected. Two A Disintegrin
And Metalloproteinases (ADAM) proteases were differentially
expressed. ADAM domain 12 (ADAM12) was down-regulated at
6 h by 2.4- fold, whereas ADAM with thrombospondin
(ADAMTS7) was up-regulated at 24 h by 2.1-fold (Table 2,
Protease and related genes). Another member of the ADAM
family, ADAM17, was previously shown to be up-regulated in T-
cells, in response to P. gingivalis [66]. The expression levels of
cysteine and serine proteases were also affected. Cysteine protease
cathepsin L (CTSL) was up-regulated at 6 h whilst elastase 1
(ELA1), a serine protease, was down-regulated at both 6 h and
24 h. By degrading extracellular matrix components, CTSL may
be involved in the metabolic turnover of bone [67]. Elastases are
capable of cleaving collagen and elastin [68], with substantial
evidence to support a role a neutrophil elastase ELA2 in the
pathogenesis of periodontitis [69–71] The down-regulation of
ELA1 in the present experimental system, may suggest a
previously uncharacterised role in the pathogenesis of periodontal
disease.
Interestingly, the expression of secretory leukocyte peptidase
inhibitor (SLPI), a serine proteinase inhibitor of elastase and
capthepsin G [72], was increased by 4.9-fold and 19.5-fold at 6 h
and 24 h, respectively (Table 2, Protease and related genes). SLPI
levels from periodontitis patients were found to be lower than
healthy individuals in GCF [73] or gingival tissue [74], compared
to healthy individuals. A decrease in SLPI GCF levels is associated
with high P. gingivalis levels in dental plaque [73], but this could be
attributed to the inhibition of the protective effect of SLPI by the
Arg-X gingipain [75]. The serine protease inhibitor (SERPIN)
gene family, comprises of several serine and selected cysteine
proteinase inhibitors that inhibit serine proteases and some
cysteine proteases, such as elastase and cathepsin L [76]. Several
SERPIN family genes were up-regulated in response to P. gingivalis
challenge, in the present experimental system. Serpin b6 and
Serpin b9 expressions were increased at 24 h, whereas Serpin 3f
and Serpin 3 g expressions were increased at both 6 h and 24 h
(Table 2, Proteases and related genes). The up-regulation of these
Serpins could be a defence mechanism against P. gingivalis, in order
to inhibit the activity of cysteine proteinases (gingipains).
Matrix metalloproteinases (MMPs) are zinc-dependent endo-
peptidases that are normally involved in tissue and extracellular
matrix remodelling, and their over-expression leads to degradation
of collagen and fibronectin, contributing to periodontal tissue and
bone destruction [28]. In response to P. gingivalis challenge, the
expression of several MMPs was up-regulated. MMP17 was up-
regulated at 6 h, whereas MMP12, MMP3 and MMP9 were up-
regulated at 24 h. In particular, MMP3 was increased by a
marked 35.8-fold at 24 h, whereas MMP13 was up-regulated at
both 6 h and 24 h, by 9.3-fold and 8.4 fold, respectively. These
findings may not be surprising, as several studies demonstrated
that P. gingivalis are capable of simulating the production of MMPs
in a variety of cell types, including periodontal ligament, human
dental pulp, and gingival fibroblast cells [77–80]. Tissue inhibitor
of metalloproteinase 1 (TIMP1), an MMP inhibitor, was also up-
regulated at 6 h by 2.1-fold. A large body of evidence demon-
strates elevated levels of MMPs in periodontal disease compared to
health [81–85]. Furthermore, there a positive correlation is
revealed clinically between the levels of P. gingivalis detected in
active sites and MMP13 levels [86]. The expression of TIMP1, an
MMP inhibitor, was also up-regulated by P. gingivalis in the present
experimental system. To this extent, P. gingivalis is able to degrade
TIMP1, with gingipains suggested as the responsible virulence
factor for this effect [80,87].
Receptors
The transcription of a number of receptors was increased in
response to P. gingivalis challenge (Table 2, Receptor genes).
Cluster of differentiation 14 (CD14), a major receptor required for
the activation of toll-like receptor complexes in response to LPS,
was up-regulated by 2.1-fold at 24 h, whereas Toll like receptor
(TLR)-2 was up-regulated by 3.7-fold and 12.6-fold, at 6 h and
24 h, respectively. A number of genes associated with the TLR-2
receptor complex, including CD14, LBP and TLR-2, were
uniformly up-regulated by P. gingivalis in the present experimental
system. Conversely, the transcription of MD-2, the co-receptor of
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TLR-4 was down-regulated in the current work. The expression of
two signaling molecules involved in downstream TLR signaling
was also affected. IRAK3, a negative regulator of TLR signaling,
and MYD88, a critical signaling component of TLR signaling,
were also increased. P. gingivalis fimbriae or its LPS are recognized
by either TLR-2 [88–90] TLR-4 [91,92] in various cell types. In
agreement with the present findings, earlier work has shown that
P. gingivalis induces TLR-2 expression [93,94]. Interestingly,
cytokine inflammatory response and alveolar bone loss was
considerably reduced in TLR-2 deficient mice, after infection
with P. gingivalis [95]. Taken together, TLR-2 is a key signaling
receptor in the recognition of P. gingivalis by host cells, and through
its down-stream pathway it may contribute to the overall
inflammatory response.
Signal Transduction and Transcription Factor Genes
Over the course of P. gingivalis challenge, the expression of
several genes involved in signal transduction was increased. As
bone marrow stromal cells can differentiate into a number of cell
types, it is not surprising that a broad array of transcription factors
have been affected. A total of 25 such genes were regulated in the
cells in response to P. gingivalis challenge (Table 2, Signal
transduction genes/Transcription factor and inhibitor genes).
The following presentation and discussion is focused on a few
such genes with relevance to the pathogenesis of periodontal
disease.
Janus kinase 2 (JAK2), a protein tyrosine kinase, was up-
regulated at 24 h by 6.9-fold. Moreover, the associated signal
transducer and activator of transcription 3 (STAT3) transcription
factor, as well as the suppressor of cytokine signalling 3 (SOCS3), a
negative regulator of cytokines that signal through the JAK/STAT
pathways, were also up-regulated. The JAK/STAT pathway is
activated when cytokines or growth factors bind to JAK-associated
receptors, which become trans-phosphorylated [96], in turn
allowing STAT transcription factors to be phosphorylated and
initiate gene transcription [97]. Live P. gingivalis has been shown to
activate STAT3 and JAK1 in gingival epithelial cells [98], and to
induce STAT1, STAT2 and SOCS1 gene expression in stromal
cells [11]. P. gingivalis FimA up-regulated, whereas LPS down-
regulated, STAT3 expression in macrophages [99]. Interestingly,
STAT3 regulates RANKL expression in osteoblasts, with impli-
cations in the initiation of mechanisms of bone resorption [100–
102].
CCAAT/enhancer-binding protein beta (C/EBPb), a transcrip-
tion factor involved in osteoblast differentiation in vivo [103] and
the induction of RANKL gene expression in osteoblast-like cells
[104], was also up-regulated in response to P. gingivalis. Thus, C/
EBPb up-regulation may contribute to the induction of RANKL
by P. gingivalis, hinting for pathways additional to the recently
identified p38 MAPK [10].
The expression of hairy-related transcription factor 1 (HEY1),
which has a negative effect on osteoblastic differentiation [105],
was increased after 6 h of challenge with P. gingivalis. As it has
recently been shown that HEY1 is involved in P. gingivalis LPS-
mediated inhibition of osteoblastic differentiation [106], the
present findings suggest that P. gingivalis may impair osteoblast
differentiation by bone marrow stromal cells, mediated by HEY1.
Components of the NF-kB complex, NF-kB 1, NF-kB 2, v-rel
reticuloendotheliosis viral oncogene homolog (REL) A and REL-B
were all up-regulated at 24 h (Table 2, Transcription factor genes).
The NF-kB is a key pathway in the activation of genes involved in
immunity and inflammation, and its deregulation can lead to
pathological conditions such as cancer and chronic inflammatory
disorders [107]. Indeed, NF-kB gingival tissue expression is higher
in chronic periodontitis, compared to health [108]. Pro-inflam-
matory cytokines, such as IL-1b, TNF-a, as well as bacterial LPS
are common inducers of NF-kB [109]. NF-kB complexes are
normally inactive and stabilized in the cytoplasm through the
association of bound IkB proteins. Phosphorylation of these
proteins by IkB kinases lead to their dissociation from the NF-KB
complex, whereby the latter are then free to translocate to the
nucleus, initiating gene transcription [107]. Interestingly, the
expression of a number of NF-kB inhibitors (BCL3, NF- kBIA,
NF-kBIE, NF-kBIZ, TNFAIP3 and TNIP1) as well as kinases
responsible for their phosphorylation (IkBKE and IkBKG) was
also up-regulated. NF-kBIZ in particular demonstrated a marked
11.2-fold and 9.6-fold up-regulation, at 6 h and 24 h, respectively.
The present findings are in agreement with previous studies
demonstrating a central role of NF-kB in the pro-inflammatory
responses to P. gingivalis in various cell types including fibroblasts,
stromal cells, gingival epithelial cells, osteoblasts, cementoblasts
and endothelial cells [11,90,93,110–112].
Components of the Activator Protein (AP)-1 transcription factor
complex jun B proto-oncogene (JUNB) and FBJ murine osteosar-
coma viral oncogene homolog (c-Fos), were also increased at 6 h
and 24 h. These findings are in agreement with earlier work
demonstrating that P. gingivalis is able to activate the AP-1
transcription factor in osteoblasts, HUVEC’s and oral epidermoid
cells [8,110,113].
Taken together, the present findings using microarray technol-
ogy support the notion that P. gingivalis can activate multiple
intracellular signalling pathways and transcription factors in a
complex manner.
Validation of Selected Microarray Data by qPCR
To interpret the results obtained from the microarray dataset, it
was important to validate representative items of the data, using
other mRNA detection assays, in this case qPCR. Therefore
RANKL, OPG and COX-2 gene expressions were assayed, as
these genes were previously shown to be regulated in the present
experimental system [9,10]. A comparable trend of expression
between the gene microarray and the qPCR results was indeed
confirmed (Table 3). To further validate the data obtained by
microarray analysis, the expression of acute phase inflammation-
associated genes LCN2 and SAA3 was also investigated by qPCR,
as these genes displayed the greatest differential regulation in the
microarray dataset. As indicated (Table 3) the trend of LCN2 and
SAA3 up-regulation at 6 h and 24 h was also confirmed by qPCR,
although the magnitude of was markedly higher by qPCR. This
could be attributed to that the dynamic range at which mRNA
expression can be measured is relatively limited by the microarray
technology, whereas qPCR assays are particularly sensitive in this
respect [114]. As the –fold changes in SAA3 expression were
among the highest measured, and these were similar among the
two time-points, a plausible explanation for the quantitative
discrepancy between the two assays is that the microarray analysis
measurements may have been saturated at this high detection
range.
Conclusions
This in vitro study employed gene microarray technology to
investigate in a temporal manner the global transcriptional events
in bone marrow stromal cells, in response to the major periodontal
pathogen Porphyromonas gingivalis. These cells have osteogenic
potential and, once exiting the bone marrow, they can differentiate
into bone forming osteoblasts, which are crucial for the
maintenance of homeostasis in the periodontal tissues. Thus, by
interfering with the transcriptional regulation of these cells, P.
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gingivalis may affect the homeostatic capacity of the tissues. The
findings demonstrate time-dependent responses of the cells to P.
gingivalis challenge. The early (6 h) responses are characterised by
enhanced expression of genes associated with inhibition of cell
cycle, induction of apoptosis and loss of structural integrity, which
can be collectively perceived as a hindrance of the basic cell
functions. The later (24 h) responses are characterised by
induction of cytokines, chemokines, mediators of connective tissue
and bone destruction, and suppression of regulators of osteogenic
differentiation. All these effects denote loss of the anabolic capacity
by the cells, switching into a catabolic phenotype that favours
inflammatory tissue destruction. However, antimicrobial protein
expression is also enhanced, potentially as a host protective
mechanism to tackle the bacterial challenge. Moreover, the
expression of genes associated with vascularisation and heme-
binging capacity is also increased. This effect, apart from being a
further inflammatory trait, could be induced by P. gingivalis as a
tactique to gain access to much needed nutrients. In conclusion, P.
gingivalis induces a diverse transcriptional profile response in bone
marrow stromal cells, with evident implications in the deregulation
of tissue homeostasis and the pathogenesis of periodontal disease.
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